
Dapinder Singh
Examiner (ID: 7865, Phone: (571)270-1774 , Office: P/3748 )
| Most Active Art Unit | 3746 |
| Art Unit(s) | 3746, 3748 |
| Total Applications | 1196 |
| Issued Applications | 994 |
| Pending Applications | 73 |
| Abandoned Applications | 157 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18451402
[patent_doc_number] => 20230192680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => NEW AGENT FOR PROMOTING PHOSPHORYLATION OF eIF2a
[patent_app_type] => utility
[patent_app_number] => 17/435592
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8555
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17435592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/435592 | NEW AGENT FOR PROMOTING PHOSPHORYLATION OF eIF2a | Mar 9, 2020 | Pending |
Array
(
[id] => 17608951
[patent_doc_number] => 20220151230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => SPECIFICALLY SUBSTITUTED 3-(2-HALOGEN-6-ALKYL-4-PROPINYLPHENYL)-3-PYRROLIN-2-ONES AND TO THE USE THEREOF AS HERBICIDES
[patent_app_type] => utility
[patent_app_number] => 17/438841
[patent_app_country] => US
[patent_app_date] => 2020-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19433
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 292
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438841
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/438841 | SPECIFICALLY SUBSTITUTED 3-(2-HALOGEN-6-ALKYL-4-PROPINYLPHENYL)-3-PYRROLIN-2-ONES AND TO THE USE THEREOF AS HERBICIDES | Mar 8, 2020 | Abandoned |
Array
(
[id] => 17640572
[patent_doc_number] => 20220168310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => INHIBITION OF ADENOVIRUS WITH FILOCICLOVIR
[patent_app_type] => utility
[patent_app_number] => 17/437236
[patent_app_country] => US
[patent_app_date] => 2020-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437236
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/437236 | INHIBITION OF ADENOVIRUS WITH FILOCICLOVIR | Mar 5, 2020 | Pending |
Array
(
[id] => 17592590
[patent_doc_number] => 20220142163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHOD OF PROTECTING FIELD CORN FROM DAMAGE BY A PLANT PATHOGEN
[patent_app_type] => utility
[patent_app_number] => 17/598500
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17598500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/598500 | METHOD OF PROTECTING FIELD CORN FROM DAMAGE BY A PLANT PATHOGEN | Feb 25, 2020 | Abandoned |
Array
(
[id] => 17578714
[patent_doc_number] => 20220135569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => INHIBITOR OF BTK AND MUTANTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/431460
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 86254
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 443
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431460
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/431460 | INHIBITOR OF BTK AND MUTANTS THEREOF | Feb 23, 2020 | Pending |
Array
(
[id] => 17973791
[patent_doc_number] => 11490624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Non-volatile organic compound pesticide formulations
[patent_app_type] => utility
[patent_app_number] => 16/792930
[patent_app_country] => US
[patent_app_date] => 2020-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4478
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16792930
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/792930 | Non-volatile organic compound pesticide formulations | Feb 17, 2020 | Issued |
Array
(
[id] => 17546610
[patent_doc_number] => 20220117951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/424070
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424070
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/424070 | COMPOSITIONS AND METHODS FOR TREATING IDIOPATHIC PULMONARY FIBROSIS | Feb 13, 2020 | Pending |
Array
(
[id] => 17741390
[patent_doc_number] => 11389435
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Compositions and methods for treating epilepsy
[patent_app_type] => utility
[patent_app_number] => 16/784362
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13835
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784362
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784362 | Compositions and methods for treating epilepsy | Feb 6, 2020 | Issued |
Array
(
[id] => 16420520
[patent_doc_number] => 20200345718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => Morphinan Derivatives for the Treatment of Drug Overdose
[patent_app_type] => utility
[patent_app_number] => 16/784574
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5329
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784574
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784574 | Morphinan Derivatives for the Treatment of Drug Overdose | Feb 6, 2020 | Abandoned |
Array
(
[id] => 17503393
[patent_doc_number] => 20220096495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => TREATMENT AND PREVENTION OF INTESTINAL INFLAMMATORY DISEASES WITH A BILE ACID DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/428029
[patent_app_country] => US
[patent_app_date] => 2020-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428029
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428029 | TREATMENT AND PREVENTION OF INTESTINAL INFLAMMATORY DISEASES WITH A BILE ACID DERIVATIVE | Feb 2, 2020 | Abandoned |
Array
(
[id] => 16539274
[patent_doc_number] => 20200405687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => METHODS FOR THE TREATMENT OF INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/779251
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14580
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16779251
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/779251 | METHODS FOR THE TREATMENT OF INFECTION | Jan 30, 2020 | Abandoned |
Array
(
[id] => 17561642
[patent_doc_number] => 20220125791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => NOVEL DEVICES
[patent_app_type] => utility
[patent_app_number] => 17/426805
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426805
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426805 | NOVEL DEVICES | Jan 27, 2020 | Abandoned |
Array
(
[id] => 17548038
[patent_doc_number] => 20220119379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => IMMUNOMODULATOR
[patent_app_type] => utility
[patent_app_number] => 17/427104
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427104
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427104 | IMMUNOMODULATOR | Jan 20, 2020 | Pending |
Array
(
[id] => 17088608
[patent_doc_number] => 11116778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Prodrugs of ALOX-15 inhibitors and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 16/961242
[patent_app_country] => US
[patent_app_date] => 2020-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 31642
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961242 | Prodrugs of ALOX-15 inhibitors and methods of using the same | Jan 13, 2020 | Issued |
Array
(
[id] => 17799081
[patent_doc_number] => 11413348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Low molecular weight cationic lipids for oligonucleotide delivery
[patent_app_type] => utility
[patent_app_number] => 16/741100
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 14
[patent_no_of_words] => 14205
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16741100
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/741100 | Low molecular weight cationic lipids for oligonucleotide delivery | Jan 12, 2020 | Issued |
Array
(
[id] => 16504714
[patent_doc_number] => 20200383970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => Morphinan Derivatives with High Oral Bioavailability
[patent_app_type] => utility
[patent_app_number] => 16/739262
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739262
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739262 | Morphinan Derivatives with High Oral Bioavailability | Jan 9, 2020 | Abandoned |
Array
(
[id] => 17460166
[patent_doc_number] => 20220073471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => 6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/419664
[patent_app_country] => US
[patent_app_date] => 2020-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22419
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17419664
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/419664 | 6-OXO-1,6-DIHYDROPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | Jan 2, 2020 | Abandoned |
Array
(
[id] => 17655293
[patent_doc_number] => 20220175758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
[patent_app_type] => utility
[patent_app_number] => 17/600194
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600194 | COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) | Dec 26, 2019 | Abandoned |
Array
(
[id] => 17685773
[patent_doc_number] => 20220193065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
[patent_app_type] => utility
[patent_app_number] => 17/600172
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600172
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600172 | COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) | Dec 26, 2019 | Abandoned |
Array
(
[id] => 17874291
[patent_doc_number] => 11446282
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Methods of treating mixed dyslipidemia and hypertriglycertdemia
[patent_app_type] => utility
[patent_app_number] => 16/726857
[patent_app_country] => US
[patent_app_date] => 2019-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14433
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16726857
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/726857 | Methods of treating mixed dyslipidemia and hypertriglycertdemia | Dec 24, 2019 | Issued |